- Home
- LENZ vs GSBC Comparison
LENZ vs GSBC Comparison
Compare LENZ & GSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LENZ
- GSBC
- Stock Information
- Founded
- LENZ 2019
- GSBC 1923
- Country
- LENZ United States
- GSBC United States
- Employees
- LENZ N/A
- GSBC N/A
- Industry
- LENZ Medicinal Chemicals and Botanical Products
- GSBC Major Banks
- Sector
- LENZ Health Care
- GSBC Finance
- Exchange
- LENZ Nasdaq
- GSBC Nasdaq
- Market Cap
- LENZ 729.6M
- GSBC N/A
- IPO Year
- LENZ 2021
- GSBC N/A
- Fundamental
- Price
- LENZ $26.01
- GSBC $55.86
- Analyst Decision
- LENZ Strong Buy
- GSBC Hold
- Analyst Count
- LENZ 6
- GSBC 1
- Target Price
- LENZ $38.00
- GSBC $64.00
- AVG Volume (30 Days)
- LENZ 252.8K
- GSBC 34.8K
- Earning Date
- LENZ 03-19-2025
- GSBC 04-16-2025
- Dividend Yield
- LENZ N/A
- GSBC 2.89%
- EPS Growth
- LENZ N/A
- GSBC N/A
- EPS
- LENZ N/A
- GSBC 5.26
- Revenue
- LENZ N/A
- GSBC $214,292,000.00
- Revenue This Year
- LENZ N/A
- GSBC N/A
- Revenue Next Year
- LENZ $535.40
- GSBC $2.25
- P/E Ratio
- LENZ N/A
- GSBC $10.53
- Revenue Growth
- LENZ N/A
- GSBC N/A
- 52 Week Low
- LENZ $14.42
- GSBC $49.74
- 52 Week High
- LENZ $38.93
- GSBC $68.02
- Technical
- Relative Strength Index (RSI)
- LENZ 56.25
- GSBC 42.27
- Support Level
- LENZ $24.10
- GSBC $56.85
- Resistance Level
- LENZ $27.89
- GSBC $58.60
- Average True Range (ATR)
- LENZ 1.77
- GSBC 1.22
- MACD
- LENZ 0.13
- GSBC -0.03
- Stochastic Oscillator
- LENZ 56.98
- GSBC 25.61
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.